Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases.

ABSTRACT:

Background

Hepatic surgery is appropriate for selected patients with colorectal liver metastases (CRLM). Advances in chemotherapy have led to modification of management, particularly when metastases disappear. Treatment should address all initial CRLM sites based on pretherapeutic cross-sectional imaging. This study aimed to evaluate pretherapeutic fiducial marker placement to optimize CRLM treatment.

Methods

This pilot investigation included patients with CRLM who were considered for potentially curative treatment between 2009 and 2016. According to a multidisciplinary team decision, lesions smaller than 25 mm in diameter that were more than 10 mm deep in the hepatic parenchyma and located outside the field of a planned resection were marked. Complication rates and clinicop

SUBMITTER: Kepenekian V 

PROVIDER: S-EPMC6551408 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature